Dexcom | DXCM - الأصول





الأصول تغيير تاريخ
Abbott USD 110.43B 23.72B 2026-03
Align Technology USD 6.52B 103.03M 2026-09
AtriCure USD 676.64M 32.66M 2026-06
Baxter International USD 19.41B 377M 2026-09
Becton, Dickinson and Co. USD 50.73B 101M 2026-06
Boston Scientific USD 45.22B 865M 2026-06
Cooper Companies USD 12.67B 191.1M 2026-06
Dexcom USD 6.24B 216.5M 2026-09
Edwards Lifesciences USD 13.87B 545.9M 2026-06
Globus Medical USD 5.49B 48.7M 2026-06
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 3.17B 177.9M 2026-06
Integra LifeSciences USD 3.51B 55.69M 2026-09
J&J USD 197.42B 3.64B 2026-09
Medtronic USD 93.31B 278M 2026-06
Merit Medical Systems USD 2.92B 61.29M 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Solventum Corp USD 14.24B 146M 2026-06
Stryker USD 47.25B 683M 2026-09
Tandem Diabetes Care USD 1.15B 808K 2026-06
Teleflex USD 6.79B 3.78M 2026-06
West Pharmaceutical Services USD 4.06B 15.7M 2026-09
Zimmer Biomet Holdings USD 22.8B 76.2M 2026-06